Special delivery: Microparticles convey heme

Blood

Volumn 125, Issue 24, 2015, Pages 3677-3678

  Vercellotti, Gregory M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; HEME; HEME OXYGENASE; HEMIN; HEMOGLOBIN; HEMOGLOBIN F; HEMOPEXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHEMOGLOBIN; NITRIC OXIDE; PORPHYRIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4;

ARTICLE; BLOOD VESSEL OCCLUSION; CELL ACTIVATION; DEOXYGENATION; ENDOTHELIUM CELL; ERYTHROCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMAN; HYDROPHOBICITY; MEMBRANE MICROPARTICLE; MESENTERY BLOOD VESSEL; NONHUMAN; OXYGENATION; PATHOPHYSIOLOGY; PHOSPHOLIPID VESICLE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN SECRETION; SICKLE CELL; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM; VASODILATATION; ANEMIA, SICKLE CELL; ANIMALS; CELL-DERIVED MICROPARTICLES; COMPLICATION; ENDOTHELIAL CELLS; HUMANS; MALE; METABOLISM; PATHOLOGY; VASCULAR DISEASES;

ANEMIA, SICKLE CELL; ANIMALS; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; HEME; HUMANS; MALE; VASCULAR DISEASES;

EID: 84931292221     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-04-639484     Document Type: Article

References (7)

1. Camus SM, De Moraes JA, Bonnin P, et al. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Blood. 2015;125(24):3805-3814.
2. Ham TH, Castle WB. Relation of increased hypotonic fragility and of erythrostasis to the mechanism of hemolysis in certain anemias. Trans Assoc Am Physicians. 1940;55:127-132.
3. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest. 1980;65(1):154-160.
4. Nouraie M, Lee JS, Zhang Y, et al Walk-PHASST Investigators and Patients. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica. 2013;98(3):464-472.
5. Muller-Eberhard U, Javid J, Liem HH, Hanstein A, Hanna M. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood. 1968;32(5):811-815.
6. Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 2013;121(8):1276-1284.
7. Belcher JD, Chen C, Nguyen J, et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 2014;123(3): 377-390.